Beneficial effect of acitretin in Chanarin-Dorfman syndrome
2011; Oxford University Press; Volume: 37; Issue: 1 Linguagem: Inglês
10.1111/j.1365-2230.2011.04164.x
ISSN1365-2230
AutoresShirli Israeli, Yakov Pessach, Ofer Sarig, Ilan Goldberg, Eli Sprecher,
Tópico(s)Cancer, Lipids, and Metabolism
ResumoJournal Article Beneficial effect of acitretin in Chanarin–Dorfman syndrome Get access S. Israeli, S. Israeli Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelDepartment of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel Search for other works by this author on: Oxford Academic Google Scholar Y. Pessach, Y. Pessach Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Search for other works by this author on: Oxford Academic Google Scholar O. Sarig, O. Sarig Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Search for other works by this author on: Oxford Academic Google Scholar I. Goldberg, I. Goldberg Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Search for other works by this author on: Oxford Academic Google Scholar E. Sprecher E. Sprecher Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelDepartment of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel Prof Eli Sprecher, Department of Dermatology, Tel Aviv Sourasky Medical Center, 6 Weizmann street, Tel Aviv 64239, Israel E‐mail: elisp@tasmc.health.gov.il Search for other works by this author on: Oxford Academic Google Scholar Clinical and Experimental Dermatology, Volume 37, Issue 1, 1 January 2012, Pages 31–33, https://doi.org/10.1111/j.1365-2230.2011.04164.x Published: 01 January 2012
Referência(s)